Maturation of vascularized cardiac organoids through the modulation of glucose and mechanical microenvironment
Active Project Grant Awarded Last action
- Award ID
- F31HL184781
- Recipient
-
University Of North Texas UEI G47WN1XZNWX9
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $73,028
Award facts
- Assistance listing
- 93.837 Cardiovascular Diseases Research
- Completion date 0% complete
- Originally
- Place of performance
- Denton, TX 76203, USA
Award details come from USAspending.gov.
Description
- Abstract
- Human-induced pluripotent stem cell-derived vascularized cardiac organoids (vcos) represent a promising in vitro model for studying human heart development, disease, and drug responses. A robust differentiation protocol has been established for generating vcos containing cardiomyocytes (CMS), endothelial cells (ECS), and cardiac fibroblasts (CFS). However, vcos remain structurally and functionally immature, limiting their utility for modeling late-onset cardiomyopathies and preclinical drug testing. Current maturation strategies enhance contractility and metabolic activity but often disrupt multicellular composition and fail to achieve key hallmarks of adult cardiac maturity, such as a compact myocardium-like structure, aligned sarcomeres and longer sarcomere length, fatty acid-dependent metabolism, hallmarks of marker gene expressions, and cardiac functions. To address these challenges, this study aims to enhance VCO maturity while preserving cellular heterogeneity by implementing a dual-modulation strategy targeting metabolism and mechanical stiffness. The first aim focuses on developing a glucose administration protocol that facilitates the metabolic transition from glycolysis to fatty acid oxidation while maintaining ECS and CFS within vcos. Optimizing glucose concentration, timing, and duration of administration is expected to enhance contractility, calcium kinetics, and mitochondrial function without compromising VCO structural integrity. The second aim introduces a stiffness-tunable biocompatible hydrogel system that mimics the mechanical transition from fetal to adult myocardium. Gradually increasing extracellular matrix stiffness during maturation is expected to improve sarcomere organization, enhance myocardial compaction, and upregulate key maturation genetic markers. Successful completion of this project will establish a physiologically relevant maturation framework for vcos, enabling advanced cardiac disease modeling and drug screening. This research aligns with the NIH's mission to develop innovative in vitro human heart models for understanding cardiovascular diseases and improving therapeutic development.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $36,514 | |
| Amendment | $0 | |
| Original award | $36,514 |
Quick answers
Who received award F31HL184781?
F31HL184781 was awarded to University Of North Texas by National Heart Lung and Blood Institute (National Institutes of Health) on December 31, 2026.
How much is award F31HL184781 worth?
$73,028 has been obligated on F31HL184781.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award